HIV Surveillance Officer (HSO) – AIDS and TB Unit: ICAP


Deadline: 4pm 25 November 2016

Under the guidance of the Monitoring and Evaluation (M&E) Coordinator seconded within the AIDS and TB Unit of the Ministry of Health and Child Care and in close liaison with M&E officers and program managers within the Unit, the HSO will support the implementation of high-quality comprehensive and robust HIV Prevention, Care and Treatment programmes in Zimbabwe through the implementation of surveys and surveillance activities, for the MOHCC HIV/TB programmes.

Major responsibilities
The roles and responsibilities for the HSO shall include, but are not limited to the following: In consultation with the MEC, participate in the development of integrated HIV/AIDS/STI/TB surveillance systems in Zimbabwe; In consultation with the Strategic Information Coordinator, coordinate the timing and implementation of AIDS and TB Unit priority surveillance systems; Support the data needs for international reporting and program planning such as required by the in-country PEPFAR team and Global Fund, among others; Provide logistical support for conducting stakeholder’s meetings for purposes of designing TB/HIV/AIDS and STI Surveillance systems including developing protocols and related standard operating procedures (SOPs) and providing training of sentinel site staff; Ensure timely tracking of routine data collection for purposes of surveillance; Provide support and supervision for routine surveillance systems; Assists in data analysis and report writing for all surveillance systems

Education
Master’s degree or equivalent in Epidemiology, Biostatistics, Health Informatics, Public Health, or related field

Experience, skills and minimum qualifications
At least seven years of experience in designing and implementing surveys and surveillance activities for National Health Programmes or rereputable international organizations particularly in the area of HIV/AIDS; Experience conducting surveillance, surveys and Operations Research; Sound knowledge of the National systems, procedures and linkages with major funding partners such as PEPFAR and Global Fund; Experience in developing and implementing evaluation projects including developing protocols, standard operating procedures, and questionnaires and data collection; Strong quantitative data management and analysis skills including demonstrated experience with statistical analysis using such programs as Epi info, Stella, SAS, SPSS & STATA; Experience conducting qualitative data collection (i.e., key informant interviews) and analyses using Computer Aided Qualitative Data Analysis Software packages as Atlasi/ti, preferred; Experience with electronic data collection tools such as DHIS 2 and Survey CTO; Good written and verbal communications skills in English; ability to interact professionally in English; Strong organizational and project management skills.

To apply
Note: The successful candidates will be employees of ICAP in Zimbabwe (and shall be seconded to MOHCC AIDS and TB Unit) and subject to the local terms and conditions of employment, which include a competitive salary and benefits package. Please forward your resume or CV to: icap-jobs-zimbabwe@columbia.edu with the position applied for in the subject line.

Or you can deliver your application and CV to ICAP in Zimbabwe office located at 39 Lawson Avenue, Milton Park, Harare, Zimbabwe, with the position being applied for clearly stated. Deadline for application is 1600hrs on the 25th of November, 2016. Only those selected for interviews will be contacted.

ICAP is an equal opportunity employer and encourages female candidates to apply. ICAP does not discriminate against employees or applicants for employment on the basis of race, color, sex, gender, religion, creed, nationality and ethnic origin, age, citizenship, status as a perceived or actual victim of domestic violence, disability, marital status, sexual orientation, or any other legally protected status.

“These positions will be supported by funding from the President Emergency Plan for AIDS Relief through US Centers for Disease Control and Prevention under terms of grant NU2GGH001939-01-00 to ICAP at Columbia University”